It has been proposed that centrosome defects may play an important role in the development of genetic abnormalities in a wide range of solid and haematological neoplasms and thus contribute to oncogenesis. 1 The majority of normal interphase cells contain one centrosome, which is comprised of two centrioles surrounded by pericentriolar material. Uncontrolled splitting of the centriole pair, cytokinesis failure after centrosome duplication and overexpression of pericentriolar material have all been suggested as mechanisms by which extra copies of centrosomes may arise. 2 An excess number of centrosomes has been described in several neoplasms, and may lead to the formation of defective mitotic spindles and a subsequent increase in chromosome segregation errors at mitosis. According to the published criteria, centrosomes are considered to be abnormal if three or more are present, if they are morphologically abnormal or if they have a diameter at least twice that of the centrosomes in nonneoplastic control cells from the same case. 2 Centrosome aberrations have been detected in several subtypes of B-cell lymphomas including mantle cell lymphoma, follicular lymphoma and diffuse large B-cell lymphoma, as well as in acute myeloid leukaemia 3, 4 (Kramer et al., Blood 2001;98: 332a, abstract). ALK-positive anaplastic large-cell lymphoma (ALCL) represents approximately 3% of non-Hodgkin's lymphomas in adults and 10-30% of paediatric lymphomas. 5 It is a T-cell-derived neoplasm characterised by the expression of CD30. The cytogenetic hallmark of ALK-positive ALCL is the t(2;5) (p23;q35) or variant rearrangements, resulting in the creation of fusion genes involving the ALK locus. Since ALK-positive ALCL differs from the B-cell lymphomas previously studied for centrosome aberrations due to its cellular origin (ie T cell) and the type of characteristic primary genetic aberration (ie a fusion gene), we have studied this subgroup of lymphomas for the presence of centrosome aberrations.
A paraffin-embedded tissue microarray (TMA) containing a total of 35 cases of ALK-positive ALCL was analysed. All cases were arranged in duplicate and 0.6 mm cores were used to construct the TMA. To determine the p53 status of the cases, immunostaining was performed using an anti-p53 antibody in conjunction with the StrepABComplex/HRP Duet Kit (both from DakoCytomation, Hamburg, Germany). A recently described rabbit antiserum against kendrin (pericentrin 2) protein was used to determine centrosome number and morphology. 6 ALCL cells were identified using a mouse monoclonal antibody against CD30 (DakoCytomation, Hamburg, Germany). Tissue sections were immunostained simultaneously with anti-pericentrin 2 and anti-CD30 followed by Cy3-conjugated donkey anti-rabbit Ig and FITC-conjugated goat anti-mouse Ig (Jackson Immunoresearch/Dianova, Hamburg, Germany). Tissue sections were then counterstained with DAPI and mounted with antifade mounting medium. Cases without acceptable pericentrin 2 or CD30 staining intensities were ignored, as were cases with less than 10 CD30-positive cells. The size, number and morphology of centrosomes were noted in at least 10 CD30-positive cells per case and in 10 CD30-negative cells per case. The latter were used as controls for the calculation of cutoff values to determine if there were significant levels of centrosome abnormalities in CD30-positive cells. Cutoff values were calculated as the mean of the percentage of centrosome abnormalities in nonmalignant CD30-negative cells plus three times the standard deviation. The cutoff values for more than twice the normal centrosome size and the presence of more than two centrosomes were 17.1 and 8.8% of the cells, respectively. The cutoff value for diffuse pericentrin staining was zero, as this was not observed in any of the CD30-negative cells evaluated. Cases that had levels of abnormalities above these values were considered to have centrosome aberrations.
In all, 17 cases of ALK-positive ALCL were considered suitable for analysis. Four cases (23%) had an elevated percentage of cells with aberrant centrosome size (median percentage of cells with aberrant centrosome size ¼ 47%, range ¼ 30-60%), three cases (18%) had an elevated percentage of cells harbouring multiple (range 3-6) centrosomes (median percentage of cells harbouring multiple centrosomes ¼ 13%, range ¼ 13-20%), but none of the cases had both types of centrosome aberration simultaneously (Figure 1a and b) . These results demonstrate that using the criteria defined above, centrosomes were structurally or numerically abnormal in seven of the 17 cases (41%) of ALK-positive ALCL studied. We considered 14 cases (82%) to have a diffuse pericentrin staining pattern (median percentage of cells with diffuse pericentrin staining ¼ 51%, range ¼ 13-92%), potentially suggesting elevated levels of pericentrin 2 protein lacking normal pericentriolar organisation (Figure 1a and c) . Of the cases studied, 16 were p53 positive (data not shown) and no correlation between centrosome aberrations and p53 staining was apparent.
The role of the described centrosome abnormalities in the oncogenesis and pathogenesis of ALCL is difficult to explain. Studies on vertebrate cells indicate that centrosomes are required for completion of cytokinesis as well as for somatic cell cycle progression from G1 into S phase, suggesting that centrosome abnormalities may have a far ranging affect on cell biochemistry and structure. Of the seven cases with centrosome abnormalities, four had enlarged centrosomes. Although enlarged centrosomes have been described previously, it remains unclear as to whether this aberration contributes to genetic instability or is simply associated with the enlarged cell size apparent in most neoplasms, that is, larger cell, therefore larger centrosome. 6 The remaining three cases had additional copies of centrosomes (range 3-6), an event that may theoretically lead to unequal chromosome separation and genetic instability. A total of 14 cases had diffuse pericentrin staining, the overexpression of which may lead to genetic abnormalities by the formation of acentriolar microtubule organising centres. A study of prostate cancer has demonstrated that the artificial overexpression of pericentrin in tumour-derived cell lines leads to the induction of centrosome defects along with genetic instability, loss of cellular architecture and the rapid growth of neoplastic cells. 7 However, despite the prevalence of centrosome aberrations, ALK-positive ALCL is relatively chromosomally stable, with a t(2;5) or variant primary translocation and only few secondary abnormalities. Therefore, the influence that centrosome aberrations have on the genetic instability of ALKpositive ALCL does not appear to be as profound as the influence that centrosome aberrations have on the genetic instability of other complex lymphomas. We conclude that using the established criteria, centrosome abnormalities are apparent in ALK-positive ALCL and may play an, as yet, undefined role in the pathogenesis of this disease. 
